Thromb Haemost 1984; 51(02): 186-188
DOI: 10.1055/s-0038-1661054
Original Article
Schattauer GmbH Stuttgart

Dihomo-γ-Linolenic Acid in Patients with Atherosclerosis: Effects on Platelet Aggregation, Plasma Lipids and Low-Density Lipoprotein-Induced Inhibition of Prostacyclin Generation

A Szczeklik
The Department of Medicine, and Pharmacology, Copernicus Academy of Medicine, Cracow, Poland
,
R J Gryglewski
The Department of Medicine, and Pharmacology, Copernicus Academy of Medicine, Cracow, Poland
,
K Sladek
The Department of Medicine, and Pharmacology, Copernicus Academy of Medicine, Cracow, Poland
,
E Kostka-Trąbka
The Department of Medicine, and Pharmacology, Copernicus Academy of Medicine, Cracow, Poland
,
A Żmuda
The Department of Medicine, and Pharmacology, Copernicus Academy of Medicine, Cracow, Poland
› Author Affiliations
Further Information

Publication History

Received 10 October 1983

Accepted 29 December 1983

Publication Date:
19 July 2018 (online)

Summary

Dihomo-γ-linolenic acid (DHLA), a precursor of monoenoic anti-aggregatory prostaglandins (PGE1, PGD2), was administered for 4 weeks in a daily dose of 1.0 g into 33 patients with atherosclerosis on a basis of a double-blind trial. Comparison of treatment and placebo groups revealed elevation of DHLA in red cell lipids in DHLA-treated subjects. No differences, however, between the two groups could be observed in platelet aggregability, thromboxane A2 generation by platelets, serum cholesterol, PGE1 and PGE2 levels, and in inhibitory activity of low-density lipoproteins against prostacyclin synthetizing system in arteries. The dietary supplementation used did not lead to distinct antithrombotic effects.

 
  • References

  • 1 Szczeklik A, Gryglewski RJ, Musial J, Grodzińska L, Serwońska M, Marcinkiewicz E. Thromboxane generation and platelet aggregation in survivals of myocardial infarction. Thromb Haemostas 1978; 40: 66-74
  • 2 Gryglewski RJ, Szczeklik A. Prostacyclin and atherosclerosis. In: Clinical Pharmacology of Prostacyclin. Lewis PJ, O’Grady J. (eds) Raven Press; New York: 1981. pp 89-95
  • 3 Silver MJ, Hock W, Kocsis JJ, Ingerman CM, Smith JB. Arachidonic acid caused sudden death in rabbits. Science 1975; 183: 1085
  • 4 Needleman P, Whitaker MO, Wyche A, Watters K, Sprecher H, Raz A. Manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: pharmacological basis for a therapeutic approach. Prostaglandins 1980; 19: 165-181
  • 5 Rose JC, Johnson M, Ramwell PW, Kot PA. Cardiovascular and platelet responses in the dog to the monoenoic prostaglandin precursor dihomo-γlinolenic acid (38727). Proc Soc Exp Biol Med 1975; 148: 1252-1256
  • 6 Lagarde M, Burtin M, Dechavanne M, Sicard B, Coiffier B. Dihomo-gammalinolenic acid (20:3 ω 6) is more anti-aggregatory than eicosapentaenoic (20 :5 ω 3) in a platelet-endothelial cell mixture. Prostaglandins Med 1980; 4: 177-183
  • 7 Gryglewski RJ, Salmon JA, Ubatuba SB, Weatherly BC, Moncada S, Vane JR. Effect of all CIS-5, 8, 11, 14, 17, eicosapentaenoic acid and PGH3 on platelet aggregation. Prostaglandins 1979; 18: 453-478
  • 8 Sim AK, McGraw AP. The activity of γ-linolenic and dihomo-γ-linolenate methyl esters in vitro and in vivo on blood platelet function in non-human primates and in man. Thromb Res 1977; 10: 385-388
  • 9 Willis AL, Stone KJ, Hart M, Gibson V, Marples P, Botfield E, Comai K, Kuhn DC. Dietary fatty acids, prostaglandins, endoperoxides and the prevention of thrombosis. In: Prostaglandins in Hematology. Silver MJ, Smith JB, Kocsis JJ. (eds) Spectrum Publ Inc; Holiswood, New York: 1977. pp 371-390
  • 10 Kernoff PB, Willis AL, Stone KJ, Davies JA, McNicol GP. Antithrombotic potential of dihomo-gamma-linolenic acid in man. Br Med J 1977; 2: 1441-1444
  • 11 Dembińska-Kieć A, Zmuda A, Grodzińska L, Bieroń K, Basista M, Kedzior A, Kostka-Trabka E, Telesz. Zelazny T. Increased platelet activity after termination of prostacyclin infusion into man. Prostaglandins 1981; 21: 827-833
  • 12 Wu KK, Hoak JC. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; 2: 923-926
  • 13 Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978; 90: 3743
  • 14 Szczeklik A, Gryglewski RJ, Domagala B, Zmuda A, Hartwich J, Woźny E, Grzywacz M, Madej J, Gryglewska T. Serum lipoproteins, lipid peroxides and prostacyclin biosynthesis in patients with coronary heart disease. Prostaglandins 1981; 22: 795-807
  • 15 Stone KJ, Willis AL, Hart M, Kirtland SJ, Kernoff PB, McNicol GP. The metabolism of dihomo-γ-linolenic acid in man. Lipids 1978; 14: 174-180
  • 16 Renaud S, McGregor L, Morazain R, Thevenon C, Benoit C, Dumont E, Mendy F. Comparative beneficial effects on platelets functions and atherosclerosis of dietary linolenic and γ-linolenic acid in rabbits. Atherosclerosis 1982; 45: 43-51
  • 17 Oelz O, Seyberth HW, Knapp Jr HR, Sweetman BJ, Oates JA. Effects of feeding ethyl-dihomo-γ-linolenate on prostaglandin biosynthesis and platelet aggregation in the rabbit. Biochim Biophys Acta 1976; 431: 268-277
  • 18 Szczeklik A, Gryglewski RJ. Low-density lipoproteins (LDL) are carriers for lipid peroxides and invalidate prostacyclin biosynthese in arteries. Artery 1980; 7: 488-495
  • 19 Nordøy A, Svensson B, Hoak J. The effects of albumin bound fatty acids on the platelet inhibitory function of human endothelial cells. Eur J Clin Invest 1979; 9: 5